Concepedia

H. Dumez

HD

Statistics

Publications

1

Citations

12

H-Index

1

Active since

2009

Affiliations

Boehringer Ingelheim (Belgium)(Current)

H. Dumez is an author at Boehringer Ingelheim (Belgium) specializing in dose adjustment assessment, solid tumor pharmacotherapy, and pharmacokinetics of anticancer drugs.

Publications per year

2009–2009

1

Publications

1

A phase I dose finding study of the 3-day administration of BIBW 2992, an irreversible dual EGFR/HER-2 inhibitor, in combination with three-weekly docetaxel in patients with advanced solid tumors

Ahmad Awada, H. Dumez, Pascal Wolter et al. · Journal of Clinical Oncology · 2009 · 12 citations

Medicine, Oncology, Pharmacology +9

1–1 of 1